Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01063442

Ligand	Ligand name	Chain	PDB	Tanimoto
BMS		A,B	1DKF	0.75
I4A	5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid	A	3FR5	0.73
DPS	3-(1H-INDOL-3-YL)-2-[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-PROPIONIC ACID	A	1CAQ	0.73
DPS	3-(1H-INDOL-3-YL)-2-[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-PROPIONIC ACID	A	1CIZ	0.73
QUA	8-HYDROXY-4-(1-HYDROXYETHYL)QUINOLINE-2-CARBOXYLIC ACID	C	2JQ7	0.7
QUA	8-HYDROXY-4-(1-HYDROXYETHYL)QUINOLINE-2-CARBOXYLIC ACID	B	1OLN	0.7
QUA	8-HYDROXY-4-(1-HYDROXYETHYL)QUINOLINE-2-CARBOXYLIC ACID	A	1E9W	0.7
BRE	2-BIPHENYL-4-YL-6-FLUORO-3-METHYL-QUINOLINE-4-CARBOXYLIC ACID	A	1D3G	0.83
LG2	6-[1-(3,5,5,8,8-PENTAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)CYCLOPROPYL]PYRIDINE-3-CARBOXYLIC ACID	A,B,C,D	1H9U	0.73
PYA	3-(1,10-PHENANTHROL-2-YL)-L-ALANINE	A	1HCW	0.71
TPV	N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE	A,B	2O4P	0.75
TPV	N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE	A	1D4S	0.75
TPV	N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE	A,B	2O4L	0.75
TPV	N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE	A	1D4Y	0.75
TPV	N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE	A,B	2O4N	0.75
F8A	9-[2-(trifluoromethyl)benzyl]-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid	A	3FR4	0.72
POO	3-CYCLOHEXYL-1-(2-{METHYL[(1-METHYLPIPERIDIN-3-YL)METHYL]AMINO}-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID	A	2BRL	0.75
9HP	9-(4-HYDROXYPHENYL)-2,7-PHENANTHROLINE	A	1PMU	0.7
SAS	2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID	A,B	13GS	0.73
ET1	3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid	A	3ET3	0.71
ET1	3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid	A,B	3ET1	0.71
ET1	3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid	A,B	3ET2	0.71
HQU	3-HYDROXYQUINALDIC ACID	C,D	193D	0.72
1IQ	2-(4-ISOPROPYL-4-METHYL-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-2-YL)QUINOLINE-3-CARBOXYLIC ACID	A	1Z8N	0.74
FBQ	1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL	A	1HBJ	0.7
MTK	MONTELUKAST	A	2NNI	0.71
CMF	3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID	A	2BRK	0.74
BRF		A	1UUO	0.82
238		A	2PRH	0.77
DY6	2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid	A,B	3DY6	0.76
ROC	N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide	A,B	2NMW	0.7
ROC	N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide	A,B	3D1Y	0.7
ROC	N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide	A,B	2NMY	0.7
ROC	N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide	A,B	3CYX	0.7
ROC	N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide	A,B	2NNP	0.7
ROC	N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide	B	1C6Z	0.7
ROC	N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide	A,B	2NNK	0.7
ROC	N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide	A	1FB7	0.7
ROC	N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide	A,B	2NMZ	0.7
ROC	N~1~-{(1S,2R)-1-benzyl-3-[(3R,4aR,8aR)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide	A,B	3D1X	0.7
WAC	N-{3-[(12bS)-7-oxo-1,3,4,6,7,12b-hexahydroindolo[2,3-a]quinolizin-12(2H)-yl]propyl}propane-2-sulfonamide	B	1S1S	0.7
QND	QUINALDIC ACID	A,B	1IDA	0.78
8CA	9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid	A	3FR2	0.74
9AC	9-ACRIDINECARBONYL	A,B,G,J,K,L,M	1G3X	0.72
NPV	4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid	A,B	2QYN	0.77
NPV	4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid	A,B	2QYK	0.77
NPV	4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid	A	2QYL	0.77
D3E	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	A,B,C,D	3D3E	0.7